Skip to content

Clinical trials

Observational Myocardial Infarction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Observational Country / region: United States Clear all

124 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20021
20034
20042
20053
20064
20078
20086
20094
20102
20118
20125
20138
20144
20158
20167
20173
20183
20196
20205
20215
20221
20231
20245
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84
Active, not recruiting10
Recruiting8
Unknown status7
Terminated6
Withdrawn6
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic7
Brigham and Women's Hospital6
National Heart, Lung, and Blood Institute (NHLBI)5
Massachusetts General Hospital4
Yale University4
AstraZeneca3
Duke University3
Johns Hopkins University3
NYU Langone Health3
University of Washington3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction124
Coronary Artery Disease28
Stroke20
Heart Failure18
Cardiovascular Diseases16
Acute Coronary Syndrome15
Myocardial Ischemia14
Atherosclerosis13
Angina Pectoris12
Heart Diseases11

Trials

Showing 1 to 25 of 124. Each trial links to its page on Pharma Observatory.

24 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.